OSL oncosil medical ltd

5.69%

$1.16

For all the grandstanding about wealth management and economics,...

First 42 Last

Share
Profile

Follow
cafa

8,918 Posts.

32

04/02/16

13:36

Post #: 16940796
Share

Originally posted by jca2978 ↑

Correct, I did join last week, and only because I saw a correlation between comments on this crappy forum and share price. Whenever a someone posts a negative, unconfirmed - no evidence to support claim about oncosil, the price sinks a little bit. They are a small cap stock, meaning that word of mouth has a higher impact on price than it should.

Simply because I joined a forum where children bad mouth stocks to drive their price down so they can either buy in or hope that competitors rise does not mean I am inexperienced when it comes to the market, I worked in wealth management for numerous years and now work in economics. I honestly hate the spirit of this forum. You fools actually speculate things that if you knew you would be breaking the law (insider information). There is no reason to think that delay on CE is a bad thing. OSL would be required to disclose the information if they received anything back from CE. If they felt negative about CE approval they would not have filed the IDE. I am positive on the likes of OncoSil because of their publicly disclosed information. They are a good prospect on paper, they have guidance from a good board, are heading in the right direction and have a product that is in need. This type of cancer treatment is needed, it is companies like OncoSil that need to succeed to actually start bringing the treatment for cancer forward.

Show me facts and I will listen. Speculate and claim to know more than me I will know you are merely a jealous trader.

Ciao!

Expand

For all the grandstanding about wealth management and economics, I beg to differ.

Most of the posts that ramp the stock are pure speculation and wishful thinking.

'OSL would be required to disclose the information if they received anything back from CE'

To state this would suggest that you have little idea of how the CE process works, nor what the asic reporting requirements are.

I wish you good luck in your speccy punt, buy please don't try and grandstand and present dubious words as some form of fact.

Last edited by cafa: 04/02/16

OSL Price at posting: 21.5¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 42 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.16		Change -0.070(5.69%)		Mkt cap ! $16.49M

Open	High	Low	Value	Volume
$1.25	$1.25	$1.11	$72.36K	60.96K

Buyers (Bids)

No.	Vol.	Price($)
1	9286	$1.16

Sellers (Offers)

Price($)	Vol.	No.
$1.18	412	1

View Market Depth

No.	Vol.	Price($)
1	9286	1.160
1	2126	1.150
1	7500	1.080
2	19761	1.050
1	2500	1.030

Price($)	Vol.	No.
1.180	412	1
1.200	8677	1
1.245	2418	1
1.250	46027	1
1.300	1500	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

OSL (ASX) Chart

For all the grandstanding about wealth management and economics,...

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

For all the grandstanding about wealth management and economics,...

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News